Physician profile
Albert Cheung
NPI 1134482466
$22,715.70
in general payments reported to CMS, 2019-2025
30 companies · $8,451 in 2025
The $8,451 reported for 2025 was more than what 95% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,011 · 2020: $166 · 2021: $217 · 2022: $4,546 · 2023: $3,677 · 2024: $3,647 · 2025: $8,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,250 · Food and Beverage: $3,792 · Consulting Fee: $3,600 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,250.00 |
| Food and Beverage | $3,791.54 |
| Consulting Fee | $3,600.00 |
| Education | $133.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $14,099.08 | 2022-2025 | Tearcare System, Omni Surgical System, Sion Surgical Instrument |
| Tarsus Pharmaceuticals, INC. | $2,556.08 | 2024-2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $1,518.80 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $839.53 | 2020-2025 | Acthar |
| Dompe US, INC. | $526.97 | 2019-2025 | Oxervate |
| Alcon Vision LLC | $458.07 | 2022-2025 | Clareon, Eysuvis, Lensx |
| Bausch & Lomb Americas INC. | $378.79 | 2022-2025 | Miebo, Xiidra, Envista Envy |
| Sun Pharmaceutical Industries INC. | $371.10 | 2019-2025 | Cequa |
| Glaukos Corporation | $346.71 | 2024-2025 | Kxl System (Not Refurbished), Photrexa Viscous and Photrexa, Radius |
| Biotissue Holdings INC. | $247.64 | 2022-2025 | |
| Alcon Research LLC | $189.03 | 2023-2024 | Precision 1, Acrysof Iq Vivity |
| Novartis Pharmaceuticals Corporation | $180.12 | 2019-2023 | |
| Oyster Point Pharma, INC. | $139.74 | 2022-2024 | Tyrvaya |
| New World Medical,INC. | $103.39 | 2023 | |
| Allergan, INC. | $96.46 | 2019-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $94.16 | 2023-2025 | Rayone Emv, Rayone Aspheric, Rayone Spheric |
| Harrow Eye, LLC | $91.81 | 2024-2025 | Vevye |
| Lombart Brothers, INC. | $82.82 | 2019 | |
| Amgen INC. | $60.85 | 2024-2025 | Tepezza |
| Kala Pharmaceuticals, INC. | $51.42 | 2019-2021 | |
| Tearlab Corp | $46.53 | 2019 | |
| Horizon Therapeutics Plc | $40.56 | 2023 | Tepezza |
| Mallinckrodt Enterprises LLC | $39.38 | 2019 | |
| Omeros Corporation | $31.06 | 2019 | |
| Aerie Pharmaceuticals, INC. | $30.68 | 2019 | |
| Shire North American Group INC | $21.24 | 2019 | |
| Ocular Therapeutix, INC. | $19.44 | 2023 | Dextenza |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.66 | 2019 | |
| Thea Pharma INC. | $16.18 | 2023 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Cheung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.